24,25(OH)2D; 25(OH)-vitamin D; Vitamin D Metabolite Ratio (VMR); analytical performance specifications biological variation; measurement uncertainty; vitamin D; Clinical Biochemistry; Biochemistry (medical); General Medicine
Abstract :
[en] [en] OBJECTIVES: The exploration of the metabolites in the degradation pathways of vitamin D (VTD) has gained importance in recent years and simultaneous quantitation of twenty-five-hydroxy vitamin D (25(OH)D) mass concentration together with 24,25-dihydroxyvitamin D (24,25(OH)2D) has been proposed as a newer approach to define VTD deficiency. Yet, no data are available on 24,25(OH)2D biological variation (BV). In this study, we evaluated 24,25(OH)2D's BV on the European Biological Variation Study (EuBIVAS) cohort samples to determine if analytical performance specifications (APS) for 24,25(OH)2D could be generated.
METHODS: Six European laboratories recruited 91 healthy participants. 25(OH)D and 24,25(OH)2D concentrations in K3-EDTA plasma were examined weekly for up to 10 weeks in duplicate with a validated LC-MS/MS method. The Vitamin D Metabolite Ratio (24,25(OH)2D divided by 25(OH)D × 100) was also calculated at each time point.
RESULTS: Linear regression of the mean 24,25(OH)2D concentrations at each blood collection showed participants were not in steady state. Variations of 24,25(OH)2D over time were significantly positively associated with the slopes of 25(OH)D concentrations over time and the concentration of 25(OH)D of the participant at inclusion, and negatively associated with body mass index (BMI), but not with age, gender, or location of the participant. The variation of the 24,25(OH)2D concentration in participants over a 10 weeks period was 34.6%. Methods that would detect a significant change linked to the natural production of 24,25(OH)2D over this period at p<0.05 would need a relative measurement uncertainty (u%)<14.9% while at p<0.01, relative measurement uncertainty should be <10.5%.
CONCLUSIONS: We have defined for the first time APS for 24,25(OH)2D examinations. According to the growing interest in this metabolite, several laboratories and manufacturers might aim to develop specific methods for its determination. The results presented in this paper are thus necessary prerequisites for the validation of such methods.
Disciplines :
Laboratory medicine & medical technology
Author, co-author :
Cavalier, Etienne ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chimie clinique
Fraser, Callum G ; Centre for Research into Cancer Prevention and Screening, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland
Bhattoa, Harjit Pal ; Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
Heijboer, Annemieke C; Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam Gastroenterology & Metabolism, Vrije Universiteit Amsterdam and University of Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
Makris, Konstantinos; Clinical Biochemistry Department, KAT General Hospital, Athens, Greece
Vasikaran, Samuel; PathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, WA, Australia
Huyghebaert, Loreen ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chimie clinique
Peeters, Stéphanie ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chimie clinique
Le Goff, Caroline ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chimie clinique
Herrmann, Markus; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
Carobene, Anna; Laboratory Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy
IFCC-IOF Committee for Bone Metabolisma
Language :
English
Title :
Analytical performance specifications for the measurement uncertainty of 24,25-dihydroxyvitamin D examinations.
Schlingmann, KP, Kaufmann, M, Weber, S, Irwin, A, Goos, C, John, U, et al.. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011;365:410-21. https://doi.org/10.1056/nejmoa1103864.
Molin, A, Baudoin, R, Kaufmann, M, Souberbielle, JC, Ryckewaert, A, Vantyghem, MC, et al.. CYP24A1 mutations in a cohort of hypercalcemic patients: evidence for a recessive trait. J Clin Endocrinol Metab 2015;100:E1343-52. https://doi.org/10.1210/jc.2014-4387.
Cavalier, E, Huyghebaert, L, Rousselle, O, Bekaert, AC, Kovacs, S, Vranken, L, et al.. Simultaneous measurement of 25(OH)-vitamin D and 24,25(OH)2-vitamin D to define cut-offs for CYP24A1 mutation and vitamin D deficiency in a population of 1200 young subjects. Clin Chem Lab Med 2019;58:197-201. https://doi.org/10.1515/cclm-2019-0996.
Tai, SSC, Nelson, MA. Candidate reference measurement procedure for the determination of (24 R),25-dihydroxyvitamin D3 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem 2015;87:7964-70. https://doi.org/10.1021/acs.analchem.5b01861.
Zelzer, S, Le Goff, C, Peeters, S, Calaprice, C, Meinitzer, A, Enko, D, et al.. Comparison of two LC-MS/MS methods for the quantification of 24,25-dihydroxyvitamin D3 in patients and external quality assurance samples. Clin Chem Lab Med 2022;60:74-81. https://doi.org/10.1515/cclm-2021-0792.
Sandberg, S, Fraser, CG, Horvath, AR, Jansen, R, Jones, G, Oosterhuis, W, et al.. Defining analytical performance specifications: consensus statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 2015;53:833-5. https://doi.org/10.1515/cclm-2015-0067.
Carobene, A, Strollo, M, Jonker, N, Barla, G, Bartlett, WA, Sandberg, S, et al.. Sample collections from healthy volunteers for biological variation estimates' update: a new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 2016;54:1599-608. https://doi.org/10.1515/cclm-2016-0035.
Cavalier, E, Fraser, CG, Bhattoa, HP, Heijboer, AC, Makris, K, Ulmer, CZ, et al.. Analytical performance specifications for 25-hydroxyvitamin D examinations. Nutrients 2021;13. https://doi.org/10.3390/nu13020431.
Sempos, CT, Betz, JM, Camara, JE, Carter, GD, Cavalier, E, Clarke, MW, et al.. General steps to standardize the laboratory measurement of serum total 25-hydroxyvitamin D. J AOAC Int 2017;100. https://doi.org/10.5740/jaoacint.17-0259.
Fabregat-Cabello, N, Farre-Segura, J, Huyghebaert, L, Peeters, S, Le Goff, C, Souberbielle, JC, et al.. A fast and simple method for simultaneous measurements of 25(OH)D, 24,25(OH)2D and the Vitamin D Metabolite Ratio (VMR) in serum samples by LC-MS/MS. Clin Chim Acta 2017;473:116-23. https://doi.org/10.1016/j.cca.2017.08.024.
Farrance, I, Frenkel, R. Uncertainty of measurement: a review of the rules for calculating uncertainty components through functional relationships. Clin Biochem Rev 2012;33:49-75.
Cochran, WG. The distribution of the largest of a set of estimated variances as a fraction of their total. Ann Hum Genet 1941;11:47-52. https://doi.org/10.1111/j.1469-1809.1941.tb02271.x.
Berg, AH, Powe, CE, Evans, MK, Wenger, J, Ortiz, G, Zonderman, AB, et al.. 24,25-Dihydroxyvitamin D3 and vitamin D status of community-dwelling black and white Americans. Clin Chem 2015;61:877-84. https://doi.org/10.1373/clinchem.2015.240051.
Sandberg, S, Carobene, A, Bartlett, B, Coskun, A, Fernandez-Calle, P, Jonker, N, et al.. Biological variation: recent development and future challenges. Clin Chem Lab Med 2023;61:741-50. https://doi.org/10.1515/cclm-2022-1255.
Carobene, A, Aarsand, AK, Bartlett, WA, Coskun, A, Diaz-Garzon, J, Fernandez-calle, P, et al.. The European Biological Variation study (EuBIVAS): a summary report. Clin Chem Lab Med 2021;60:505-17. https://doi.org/10.1515/cclm-2021-0370.
Carobene, A, Campagner, A, Uccheddu, C, Banfi, G, Vidali, M, Cabitza, F. The multicenter European Biological Variation Study (EuBIVAS): a new glance provided by the Principal Component Analysis (PCA), a machine learning unsupervised algorithms, based on the basic metabolic panel linked measurands. Clin Chem Lab Med 2021;60:556-68. https://doi.org/10.1515/cclm-2021-0599.
